Dr Michelle Anne Novakovich, AUD in High Point, NC - Medicare Provider

Dr Michelle Anne Novakovich, AUD is a medicare enrolled "Audiologist-hearing Aid Fitter" provider in High Point, North Carolina. Her current practice location is 1008 Hutton Ln, Suite 107, High Point, North Carolina. You can reach out to her office (for appointments etc.) via phone at (336) 884-5929.

Dr Michelle Anne Novakovich is licensed to practice in North Carolina (license number 5289) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1114122181.

Contact Information

	Dr Michelle Anne Novakovich, AUD
	1008 Hutton Ln, Suite 107, High Point, NC 27262-7244
	(336) 884-5929
	(336) 884-4081

Healthcare Provider's Profile

Full Name	Dr Michelle Anne Novakovich
Gender	Female
Speciality
Experience	Years
Location	1008 Hutton Ln, High Point, North Carolina
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Michelle Anne Novakovich attended and graduated from in

NPI Data:

NPI Number: 1114122181
Provider Enumeration Date: 06/19/2007
Last Update Date: 09/02/2014

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for Dr Michelle Anne Novakovich such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1114122181	NPI	-	NPPES
7001527	Medicaid	NC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	5289 (North Carolina)	Secondary
237600000X	Audiologist-hearing Aid Fitter	5289 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michelle Anne Novakovich is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Michelle Anne Novakovich, AUD 1008 Hutton Ln, Suite 107, High Point, NC 27262-7244 Ph: (336) 884-5929	Dr Michelle Anne Novakovich, AUD 1008 Hutton Ln, Suite 107, High Point, NC 27262-7244 Ph: (336) 884-5929

News Archive

Alkermes announces results from phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia

Alkermes plc today announced positive topline results from a randomized, double-blind, placebo-controlled phase 3 clinical trial of aripiprazole lauroxil in patients with schizophrenia. Patients treated once monthly with either 441 mg or 882 mg of aripiprazole lauroxil demonstrated statistically significant reductions from baseline in Positive and Negative Syndrome Scale (PANSS) total scores at week 12, compared to placebo (p<0.001 aripiprazole lauroxil 441 mg, p<0.001 aripiprazole lauroxil 882 mg), which was the prespecified primary endpoint in the study. Based on the positive results from this phase 3 study, Alkermes plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) in the third quarter of 2014.

Innovent Biologics and MD Anderson to develop sintilimab injection for rare cancers

The University of Texas MD Anderson Cancer Center and Innovent Biologics, Inc. today announced a strategic collaboration agreement to co-develop TYVYT® (sintilimab injection), Innovent's anti-PD-1 monoclonal antibody, in rare cancers in the U. S...

Some people treated for type 1 diabetes may have monogenic diabetes, study finds

A Joslin Diabetes Center study among people treated for type 1 diabetes for many years has discovered that a minority may have monogenic diabetes, a non-autoimmune inherited condition that in some cases does not require insulin treatment.

A wrenching farewell: Bidding adieu to my primary care doctor after nearly 30 years

I hadn't expected the tears. My primary care doctor and I were saying goodbye after nearly 30 years together.

Peptilogics held pre-IND meeting with FDA to develop PLG0206 for treating prosthetic joint infections

Peptilogics, a development stage company utilizing its innovative peptide platform to treat multidrug-resistant bacterial infections, today announced it recently held a pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration to discuss the regulatory pathway for the development of PLG0206 for the treatment of prosthetic joint infections.

Dr Michelle Anne Novakovich, AUD - Medicare in High Point, NC